S.C. Carmeco S.A. (BVB:CRMC)
0.1820
-0.0780 (-30.00%)
At close: Jun 10, 2025
CTI BioPharma Balance Sheet
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.02 | 0.04 | 0.04 | 0.13 | 0.2 | 0.03 | Upgrade |
Cash & Short-Term Investments | 0.02 | 0.04 | 0.04 | 0.13 | 0.2 | 0.03 | Upgrade |
Cash Growth | 120.71% | -2.72% | -67.33% | -34.71% | 524.77% | -68.06% | Upgrade |
Accounts Receivable | 0.44 | 0.25 | 0.51 | 0.31 | 0.19 | 0.47 | Upgrade |
Other Receivables | 0.43 | 0.36 | - | - | - | - | Upgrade |
Receivables | 0.87 | 0.62 | 0.51 | 0.31 | 0.19 | 0.47 | Upgrade |
Inventory | 0.54 | 0.54 | 0.17 | - | - | 0 | Upgrade |
Other Current Assets | 0 | 2.5 | 1.22 | - | - | - | Upgrade |
Total Current Assets | 1.43 | 3.7 | 1.94 | 0.44 | 0.39 | 0.5 | Upgrade |
Property, Plant & Equipment | 11.92 | 11.9 | 11.99 | 11.56 | 11.66 | 11.94 | Upgrade |
Long-Term Investments | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Other Long-Term Assets | 3.14 | - | - | - | - | - | Upgrade |
Total Assets | 16.5 | 15.59 | 13.93 | 12 | 12.05 | 12.44 | Upgrade |
Accounts Payable | 0.21 | - | - | - | - | - | Upgrade |
Current Unearned Revenue | - | - | - | - | 0.01 | 0.57 | Upgrade |
Other Current Liabilities | - | 0.21 | 0.21 | 0.05 | 0.09 | 0.14 | Upgrade |
Total Current Liabilities | 0.21 | 0.21 | 0.21 | 0.05 | 0.1 | 0.71 | Upgrade |
Other Long-Term Liabilities | 4.01 | 3.34 | 1.68 | -0.08 | -0.02 | -0 | Upgrade |
Total Liabilities | 4.48 | 3.55 | 1.89 | -0.02 | 0.08 | 0.71 | Upgrade |
Common Stock | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 | Upgrade |
Retained Earnings | -5.27 | -5.25 | -5.26 | -5.28 | -5.33 | -5.6 | Upgrade |
Comprehensive Income & Other | 10.13 | 10.13 | 10.13 | 10.13 | 10.13 | 10.16 | Upgrade |
Shareholders' Equity | 12.02 | 12.04 | 12.04 | 12.02 | 11.97 | 11.73 | Upgrade |
Total Liabilities & Equity | 16.5 | 15.59 | 13.93 | 12 | 12.05 | 12.44 | Upgrade |
Net Cash (Debt) | -0.23 | 0.04 | 0.04 | 0.13 | 0.2 | 0.03 | Upgrade |
Net Cash Growth | - | -2.72% | -67.33% | -34.71% | 524.77% | -68.06% | Upgrade |
Net Cash Per Share | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade |
Filing Date Shares Outstanding | 71.69 | 71.69 | 71.69 | 71.69 | 71.69 | 71.69 | Upgrade |
Total Common Shares Outstanding | 71.69 | 71.69 | 71.69 | 71.69 | 71.69 | 71.69 | Upgrade |
Working Capital | 1.21 | 3.49 | 1.73 | 0.39 | 0.29 | -0.21 | Upgrade |
Book Value Per Share | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.16 | Upgrade |
Tangible Book Value | 12.02 | 12.04 | 12.04 | 12.02 | 11.97 | 11.73 | Upgrade |
Tangible Book Value Per Share | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.16 | Upgrade |
Land | - | 11.12 | 11.12 | 11.12 | 11.12 | 11.12 | Upgrade |
Buildings | - | 3.12 | 3.12 | 3.12 | 3.12 | 3.37 | Upgrade |
Machinery | - | 1.13 | 1.1 | 0.63 | 0.63 | 0.63 | Upgrade |
Construction In Progress | - | 0 | 0 | 0 | 0 | - | Upgrade |
Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.